S4-E33.4 - More Presentation Insights on Frequency of Testing, NITs and Biopsy

Send us Fan MailThroughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions. For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss a range of fascinating topics to emerge at the EASL Congress meeting held in Vienna.This final conversation begins with Sven's choice to discuss another paper by Vincent Wong that correlated liver stiffness with risk of decompensation and HCC. It is noted that the study relied on repetitive MRE readings over time and could not be performed in many different countries. This leads to comments around the plausibility of shifting from biopsy to NITs and insights around the cost effectiveness and the frequency of testing. On the flip side, Ian next underscores a study that investigates identification of a gene signature that will accurately predict the risk of decompensation and, ultimately, determine how to make better use of the biopsy tissue received in research. Finally, the session winds down with a closing question around what to expect in next year's meeting. If you have questions or comments around the EASL Congress meeting, new nomenclature, discussed papers or any other ideas addressed in this episode, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at [email protected] Safe and Surf On!